Corient Capital Partners, LLC Organon & Co. Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Organon & Co. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 7,514 shares of OGN stock, worth $144,118. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,514Holding current value
$144,118% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding OGN
# of Institutions
795Shares Held
191MCall Options Held
1.59MPut Options Held
931K-
Black Rock Inc. New York, NY32.6MShares$625 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$579 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.1MShares$194 Million0.07% of portfolio
-
State Street Corp Boston, MA9.01MShares$173 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V77.43MShares$143 Million0.19% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.88B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...